Ertapenem Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-199

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ertapenem (NDC 25021-199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Ert04 0000 01)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ert04 0000 02)

Package Label – Principal Display Panel – Vial Label (Ert04 0000 02)
This text appears to be information about a medication or healthcare product. It mentions "Intravenous or Intramuscular Use", a "Single-Dose Vial", and provides guidance to discard any unused portion. The details are related to a product usage and specifications.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.